A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...
Audacy on MSN
The story of KJ Muldoon: The baby who received ground-breaking gene-editing therapy at CHOP
VIPs gathered last week for the final beam placement in Children’s Hospital of Philadelphia’s new 26-story tower. But the ...
Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...
A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...
In November, six months after KJ’s debut, top Food and Drug Administration officials Marty Makary and Vinay Prasad published ...
A new skin-applied gene therapy uses lipid nanoparticles to deliver gene editing into skin stem cells, correcting ...
Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...
Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing ...
Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.
In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...
U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the ...
Wave claimed GSK is handing back rights to the frontrunning program not because of questions about its potential, but because ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results